Benefit, rather than safety, of cilostazol for long-term mortality in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Benefit, rather than safety, of cilostazol for long-term mortality in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials

Published:2011-11 Issue:1 Volume:153 Page:74-76
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Takagi Hisato,Umemoto Takuya

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials;Regensteiner;J Am Geriatr Soc,2002

2. Cilostazol: a review of its use in intermittent claudication;Chapman;Am J Cardiovasc Drugs,2003

3. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group;Packer;N Engl J Med,1991

4. Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: a study in long-term effects);Hiatt;J Vasc Surg,2008

5. Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up;Ahn;Heart Vessels,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive Cilostazol in Patients With High Residual Platelet Reactivity After Drug-Eluting Stent Implantation: A Randomized, Open-Label, Single-Center, Prospective (ADJUST-HPR) Study;American Journal of Therapeutics;2023-04-25

2. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications;The Journal of Clinical Pharmacology;2021-11-25

3. Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study;BioMed Research International;2016

4. Pharmacodynamic Effects of Cilostazol Versus Clopidogrel in Stented Patients under Proton Pump Inhibitor Co-administration: The ACCEL-PARAZOL Study;Journal of Atherosclerosis and Thrombosis;2014

5. Cilostazol—A Forgotten Antiplatelet Agent, But Does it Even Matter?;JACC: Cardiovascular Interventions;2013-09